About Noble Life Sciences
Noble Life Sciences is a company based in Woodbine (United States) founded in 2010. Noble Life Sciences has raised $335 thousand across 2 funding rounds from investors including TEDCO. Noble Life Sciences offers products and services including Preclinical Testing, Bioanalysis, Flow Cytometry, and Toxicology Services. Noble Life Sciences operates in a competitive market with competitors including TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
- Headquarter Woodbine, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$335 K (USD)
in 2 rounds
-
Latest Funding Round
$100 K (USD), Seed
Jun 01, 2013
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Noble Life Sciences
Noble Life Sciences offers a comprehensive portfolio of products and services, including Preclinical Testing, Bioanalysis, Flow Cytometry, and Toxicology Services.
Conducts safety and efficacy tests for drugs and devices.
Performs testing for pharmacodynamic modeling in drug development.
Analyzes immune cells in preclinical oncology studies.
Evaluates toxicity in animal models for therapeutic development.
People of Noble Life Sciences
Unlock access to complete
Unlock access to complete
Funding Insights of Noble Life Sciences
Noble Life Sciences has successfully raised a total of $335K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $100 thousand completed in June 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Noble Life Sciences
Noble Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Locked | Locked | Locked |
Investor details for Noble Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Noble Life Sciences
Investment portfolio details for Noble Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Noble Life Sciences
Detailed financials for Noble Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Noble Life Sciences Comparisons
Peer comparison for Noble Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Noble Life Sciences
Noble Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransCure bioServices, GenOway, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| Locked | Locked | Locked |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| Locked | Locked | Locked |
Animal models are supplied for in-vivo analytical services.
|
Detailed competitors of Noble Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Noble Life Sciences
Complete news archive for Noble Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Noble Life Sciences
Noble Life Sciences was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Noble Life Sciences is headquartered in Woodbine, United States. It is registered at Woodbine, New Jersey, United States.
Noble Life Sciences is a funded company, having raised a total of $335K across 2 funding rounds to date.
Noble Life Sciences is a preclinical contract research organisation offering standard GLP and non-GLP services, including safety and efficacy testing, for the development of drugs, vaccines, and medical devices. They offer preclinical testing in a wide variety of mammalian species including rabbits, rats, mice, ferrets, guinea pigs, sheep, goats, domestic swine and mini pigs. Their services also include the derivation and maintenance of animal breeding colonies, animal housing and husbandry, the production of custom antibodies, and the development of disease and animal models. The company offers specialised services for oncology drug evaluation, polyclonal antibody production and vaccine development.
Noble Life Sciences's top competitors include GenOway, PsychoGenics and Alpha Genesis.
Noble Life Sciences offers Preclinical Testing, Bioanalysis, Flow Cytometry, and Toxicology Services.
Noble Life Sciences has 1 investor. Key investors include TEDCO.